Skip to main content
Log in

Efficacy and safety of fractionated conformal radiation therapy in acromegaly: a long-term follow-up study

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background and purpose

Conformal, fractionated radiation therapy (XRT) is variably used as a treatment alternative for active acromegaly patients, usually, after failed pituitary surgery. Our objective was to evaluate the long-term efficacy and safety of XRT using strict criteria of biochemical control.

Setting, design, patients, and methods

Retrospective cohort study of 94 patients (73 women, mean age at radiation 53.16 ± 12.9 years) attending a specialized multidisciplinary clinic between 1998 and 2014 with a mean duration of follow-up of 12.9 ± 7.3 years.

Results

A basal growth hormone < 1 ng/mL and an IGF-1 < 1.2 × the upper limit of normal was achieved by 41% and 50.8%, respectively, at 5 years of follow-up, and by 44% and 66%, respectively, 10 years after XRT. Median tumor volume decreased significantly from 904 mm3 at baseline to 424 mm3 upon last follow-up (p = 0.01). The prevalence of central hypogonadism, central hypocortisolism, and central hypothyroidism increased from 18%, 35%, and 35% at baseline, to 38%, 53%, and 64%, respectively, after 10 years of follow-up. One patient was diagnosed with a meningioma and another one developed optic neuritis. No cerebrovascular events were recorded, and all patients are currently alive.

Conclusion

XRT is an effective and reasonably safe means of controlling acromegalic activity. Its main disadvantages are the time required to achieve biochemical control and the development of anterior pituitary hormone deficiencies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. S. Melmed, Acromegaly pathogenesis and treatment. J. Clin. Invest. 119, 3189–3202 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. E. Espinosa, C. Ramirez, M. Mercado, The multimodal treatment of acromegaly: current status and future perspectives. DEndocr. Immune. Disord. Drug. Targets 14, 169–181 (2014)

    Article  CAS  Google Scholar 

  3. G. Minniti, C. Scaringi, R.M. Enrici, Radiation techniques for acromegaly. Radiat. Oncol. 6, 167 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  4. M. Mercado, E. Espinosa, C. Ramirez, Current status and future directions of pharmacological therapy for acromegaly. Minerva Endocrinol. 41, 351–265 (2016)

    PubMed  Google Scholar 

  5. A.L. Espinosa-de-los-Monteros, B. Gonzalez, G. Vargas, E. Sosa, M. Mercado, Octreotide LAR treatment of acromegaly in “real life”: long term outcome at a tertiary care center. Pituitary 18, 290–296 (2015)

    Article  CAS  PubMed  Google Scholar 

  6. S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanueva, J.A.H. Wass et al. A consensus on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14, 552–561 (2018)

    Article  PubMed  Google Scholar 

  7. M.D. Bronstein, O.D. Bruno, A. Abreu, R. Mangupli, M. Mercado, A practical approach to acromegaly management in Latin America. Pituitary 17, s30–s35 (2014)

    Article  PubMed  Google Scholar 

  8. L.A. Portocarrero-Ortiz, A. Vergara-López, M. Vidrio-Velazquez, A.M. Uribe-Días, A. García-Domínguez, A. Reza-Albarrán, D. Cuevas-Ramos, V. Melgar, J. Talavera, A.J. Rivera-Hernández, C.V. Valencia-Méndez, M. Mercado; (The Mexican Acromegaly Registry Group), The Mexican Acromegaly Registry: clinical-biochemical characteristics at diagnosis and therapeutic outcomes. J. Clin. Endocrinol. Metab. 101, 3997–4004 (2016)

    Article  CAS  PubMed  Google Scholar 

  9. T. Ertekin, N. Hacer, A.T. Turgut, K. Aycan, O. Ozceli, M. Turgut, Comparison of three methods for the estimation of pituitary volume using magnetic resonance imaging: a stereological study. Pituitary 14, 31–38 (2011)

    Article  PubMed  Google Scholar 

  10. J. Roth, P. Gorden, K. Brace, Efficacy of conventional pituitary irradiation in acromegaly. N. Engl. J. Med. 282, 1385–1391 (1970)

    Article  CAS  PubMed  Google Scholar 

  11. R. Eastman, P. Gorden, J. Roth, Conventional supervoltage irradiation is an effective treatment for acromegaly. J. Clin. Endocrinol. Metab. 48, 931–940 (1979)

    Article  CAS  PubMed  Google Scholar 

  12. P.J. Jenkins, P. Bates, N. Carson, P.M. Stewart, J.A.H. Wass, Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J. Clin. Endocrinol. Metab. 91, 1239–1245 (2006)

    Article  CAS  PubMed  Google Scholar 

  13. R.S. Jallad, N.R. Musolino, L.R. Salgado, M.D. Bronstein, Treatment of acromegaly: Is there still a place for radiotherapy. Pituitary 10, 53–59 (2007)

    Article  PubMed  Google Scholar 

  14. G. Barrande, M. Pittino-Lungo, J. Coste, D. Ponvert, X. Bertagna, J.P. Luton, J. Bertherat, Hormonal and metabolic effects of radiotherapy in acromegaly: Long term results in 128 patients followed in a single centre. J. Clin. Endocrinol. Metab. 85, 3779–3785 (2000)

    Article  CAS  PubMed  Google Scholar 

  15. A.L. Barkan, I. Halasz, K.J. Dornfield, C.A. Jaffe, R.D. Friberg, W.F. Chandler, H.M. Sandler, Pituitary irradiation is ineffective in normalization of insulin-like growth factor-I in patients with acromegaly. J. Clin. Endocrinol. Metab. 82, 3187–3191 (1997)

    CAS  PubMed  Google Scholar 

  16. N.C. Thalassinos, S. Tsagarakis, G. Ioannides, I. Tzavara, C. Papavasilau, Megavoltage pituitary irradiation lowers but seldom leads to “safe” GH levels in acromegaly: a long-term follow up study. Eur. J. Endocrinol. 138, 160–163 (1998)

    Article  CAS  PubMed  Google Scholar 

  17. N.R. Biermasz, H. van Dulken, F. Roelfsema, Long-term follow up results of postoperative radiotherapy in 36 patients with acromegaly. J. Clin. Endocrinol. Metab. 85, 2476–2482 (2000)

    Article  CAS  PubMed  Google Scholar 

  18. J.S. Powell, S.L. Wardlaw, K.D. Post, P.D. Freda, Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor-I to define cure. J. Clin. Endocrinol. Metab. 85, 2068–2071 (2000)

    CAS  PubMed  Google Scholar 

  19. P. Epaminonda, S. Poretti, V. Capiello, P. Beck-Pecoz, G. Faglia, M. Arosio, Efficacy of radiotherapy in normalizing serum IGF-1, acid-labile subunit (ALS) and IGFBP3 levels in acromegaly. Clin. Endocrinol. 55, 183–189 (2001)

    Article  CAS  Google Scholar 

  20. G. Minniti, M.L. Jaffrain-Rea, M. Osti, V. Esposito, A. Santoro, F. Salda, P. Gargiulo, G. Tamburano, R.M. Enrici, The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin. Endocrinol. 62, 210–216 (2005)

    Article  Google Scholar 

  21. K. Mullan, C. Sanabria, W.P. Abram, E.M. McConnell, H.C. Courtney, S.J. Hunter et al. Long-term effect of external pituitary irradiation on IGF-1 levels in patients with acromegaly free of adjunctive treatment. Eur. J. Endocrinol. 161, 547–551 (2009)

    Article  CAS  PubMed  Google Scholar 

  22. B. Gonzalez, G. Vargas, A.L. Espinosa-de-los-Monteros, E. Sosa, M. Mercado, Efficacy and safety of radiotherapy in acromegaly. Arch. Med. Res. 42, 48–52 (2011)

    Article  PubMed  Google Scholar 

  23. H. Patt, R. Jalali, C. Yerawar, S. Khore, T. Gupta, A. Gael et al. High precision conformal fractionated radiotherapy is effective in achieving remission in patients with acromegaly after failed transsphenoidal surgery. Endocr. Pract. 22, 162–172 (2016)

    Article  PubMed  Google Scholar 

  24. O. Alexopoulou, M. Bex, R. Abs, E. T’Sjoen, B. Velkeniers, D. Maiter, Divergence between growth hormone and insulin-like growth factor-1 concentrations in the follow up of acromegaly. J. Clin. Endocrinol. Metab. 93, 1324–1330 (2008)

    Article  CAS  PubMed  Google Scholar 

  25. A.L. Espinosa-de-los-Monteros, E. Sosa, S. Cheng, R. Ochoa, C. Sandoval, G. Guinto, V. Mendoza, I. Hernández, M. Molina, Mercado:biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status. Clin. Endocrinol. 64, 245–249 (2006)

    Article  CAS  Google Scholar 

  26. J. Ayuk, R.N. Clayton, G. Holder, M.C. Sheppard, P.M. Stewart, A.S. Bates, Growth hormone and pituitary radiotherapy but not serum insulin-like growth factor-I concentrations predict excess mortality in patients with acromegaly. J. Clin. Endocrinol. Metab. 89, 1613–1617 (2004)

    Article  CAS  PubMed  Google Scholar 

  27. M. Arosio, G. Reimondo, E. Malchiodi, P. Berchialla, A. Borraccino, L. De Marinis et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur. J. Endocrinol. 167, 189–198 (2012)

    Article  CAS  PubMed  Google Scholar 

  28. F. Bogazzi, A.M. Colao, G. Rossi, M. Lombardi, C. Urbani, C. Sardella et al. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur. J. Endocrinol. 169, 367–376 (2013)

    Article  CAS  PubMed  Google Scholar 

  29. M. Mercado, B. Gonzalez, G. Vargas, C. Ramirez, A.L. Espinosa-de-los-Monteros, E. Sosa et al. Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J. Clin. Endocrinol. Metab. 99, 4438–4446 (2014)

    Article  CAS  PubMed  Google Scholar 

  30. J.S. Loeffler, H.A. Shih, Radiation therapy in the management of pituitary adenomas. J. Clin. Endocrinol. Metab. 96, 1992–2003 (2011)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Moisés Mercado.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

Study was approved by our local Ethics and Scientific Committees.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gonzales-Virla, B., Vargas-Ortega, G., Martínez-Vázquez, KB. et al. Efficacy and safety of fractionated conformal radiation therapy in acromegaly: a long-term follow-up study. Endocrine 65, 386–392 (2019). https://doi.org/10.1007/s12020-019-01955-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-01955-4

Keywords

Navigation